Facial Fillers in Aesthetic Practice: Patient Satisfaction and Overview of Common Adverse Effects: A Cross-Sectional Study

Document Type : Original Article

Authors

1 General practitioner (MD(, Restorative Cosmetic Doctor, Private Practice, Tehran, Iran

2 Trauma and injury Research center,Iran university of medical sciences,Tehran,Iran

Abstract
Facial fillers have become an integral component of aesthetic practice due to their ability to restore facial volume, smooth wrinkles, and enhance contour with minimally invasive techniques. This cross-sectional study aimed to evaluate patient satisfaction and document the prevalence and types of common adverse effects associated with facial filler treatments. A total of 200 patients who received various types of dermal fillers were surveyed using structured questionnaires focusing on treatment outcomes, satisfaction levels, and any experienced complications. Results demonstrated a high overall patient satisfaction rate, with 85% of participants reporting improvements in facial aesthetics and a positive impact on self-confidence. The majority of patients favored the minimally invasive nature and rapid recovery associated with filler procedures. However, 30% of participants reported experiencing mild to moderate adverse effects, the most frequent being transient erythema, swelling, bruising, and tenderness at the injection site. Less common but notable complications included lumps, asymmetry, and, rarely, vascular occlusion. The study highlights the importance of proper patient selection, practitioner expertise, and post-procedural care in optimizing outcomes and minimizing risks. Additionally, patient education regarding potential side effects and realistic expectations is essential to maintaining satisfaction. This study provides valuable insights into the safety profile and patient perspectives of facial fillers in aesthetic medicine, reinforcing their role as effective yet not risk-free interventions.

Graphical Abstract

Facial Fillers in Aesthetic Practice: Patient Satisfaction and Overview of Common Adverse Effects: A Cross-Sectional Study

Keywords

Subjects

In recent years, facial fillers have revolutionized the field of aesthetic medicine by providing a minimally invasive option for facial rejuvenation and contouring. The global demand for cosmetic procedures has risen dramatically, with dermal fillers becoming one of the most commonly performed non-surgical aesthetic treatments worldwide. This surge in popularity is largely driven by patients’ desires to achieve a youthful appearance, restore lost facial volume, and correct age-related changes without undergoing invasive surgery or prolonged recovery times [1].

Background and Significance of the Study

Facial aging is a complex process characterized by a combination of volume loss, skin laxity, and changes in bone structure. The gradual depletion of subcutaneous fat and collagen contributes to the appearance of wrinkles, folds, and sagging skin. Dermal fillers, particularly hyaluronic acid (HA)-based products, have been extensively used to counteract these changes by replenishing volume and smoothing superficial lines. Other types of fillers, including calcium hydroxylapatite (CaHA), poly-L-lactic acid (PLLA), and polymethylmethacrylate (PMMA), provide additional options for tailored treatment plans based on patient needs and treatment goals [2].

The versatility and effectiveness of facial fillers have led to their widespread adoption among dermatologists, plastic surgeons, and other aesthetic practitioners. Their use extends beyond the wrinkle correction to include lip augmentation, nonsurgical rhinoplasty, and enhancement of facial contours such as the cheeks and jawline. The relatively low risk profile and quick procedure time further enhance their appeal [3].

 Patient Satisfaction in Aesthetic Practice

Patient satisfaction is a critical metric in aesthetic medicine, reflecting the success of treatment from the patient’s perspective. Satisfaction is influenced not only by the clinical outcomes, but also by the patient’s expectations, the quality of the consultation, the skill of the practitioner, and post-treatment care. Studies have generally reported high satisfaction rates following facial filler treatments, with patients appreciating the immediate and natural-looking results. The improvement in self-esteem and social confidence reported by many patients underscores the psychosocial benefits of these procedures [4].

However, satisfaction is not universal, and factors such as unrealistic expectations, suboptimal injection techniques, or adverse effects can negatively impact patient perception. Therefore, comprehensive patient assessment, clear communication regarding potential outcomes, and informed consent are paramount [5].

 

Common Adverse Effects of Facial Fillers

Despite their favorable safety profile, facial fillers are associated with a spectrum of adverse effects ranging from mild and transient to rare but severe complications. The most common side effects include erythema (redness), swelling, bruising, and tenderness at the injection sites. These reactions are typically self-limiting and resolve within days to weeks [5-7].

More significant complications, though rare, include nodules or lumps, infections, allergic reactions, and vascular occlusions leading to tissue necrosis or even blindness. Vascular compromise occurs when filler material inadvertently enters an artery, causing obstruction of blood flow. This underscores the necessity of thorough knowledge of facial anatomy and injection techniques to minimize risks [8].

Granuloma formation, delayed inflammatory reactions, and migration of filler material are also reported but occur less frequently. Management of complications requires prompt recognition and 0appropriate intervention, often involving hyaluronidase injections to dissolve HA fillers or other medical therapies [9-11].

 

The Need for Cross-Sectional Studies

Given the rapid growth in facial filler use and the diversity of products and techniques available, ongoing evaluation of patient outcomes and safety is essential. Cross-sectional studies provide valuable snapshots of real-world patient experiences, capturing data on satisfaction and adverse effects from diverse populations. Such studies can identify risk factors, inform clinical guidelines, and enhance patient education [12].

Furthermore, understanding demographic variables such as age, sex, skin type, and previous aesthetic treatments helps tailor approaches to maximize benefits and reduce complications. Cultural and regional differences also affect patient expectations and acceptance of cosmetic procedures, which can be clarified through comprehensive studies [13-15].

 Challenges and Considerations

Despite the advantages, several challenges remain in the use of facial fillers. The variability in product composition, longevity, and tissue integration requires practitioners to be well-versed in multiple filler types and their indications. Training and certification standards vary globally, impacting the consistency and quality of care [15-17].

Moreover, the rise of unregulated providers and “DIY” treatments possess significant public health concerns. Cases of severe complications have been reported due to improper techniques or counterfeit products. Regulatory oversight and public awareness are critical to safeguarding patient safety [18-20].

Ethical considerations, including managing patient expectations and addressing psychological motivations for cosmetic procedures, also play a vital role. Practitioners must ensure treatments align with patients’ well-being and realistic goals (Table 1).

Table 1: A curated table of 25 scholarly references in APA format related to “Facial Fillers in Aesthetic Practice: Patient Satisfaction and Common Adverse Effects”, along with concise explanations of their key contributions [9].

Reference (APA)

Study Focus

Key Findings / Contributions

Beleznay, K., et al. (2015). Vascular complications of soft tissue fillers: prevention and treatment. Dermatologic Surgery, 41(10), 1097-1117.

Vascular complications

Guidelines for recognition and managing vascular occlusion

Chatrath, V., et al. (2016). Complications of hyaluronic acid fillers and their management. Clinical, Cosmetic and Investigational Dermatology, 9, 295-316.

HA complications

Comprehensive review of side effects and the best management practices

DeLorenzi, C. (2014). Complications of injectable fillers, part 2: Vascular complications. Aesthetic Surgery Journal, 34(4), 584-600.

Vascular risks

Detailed analysis of anatomy-based injection safety

Funt, D., & Pavicic, T. (2013). Dermal fillers in aesthetics: overview of adverse events. Clinical, Cosmetic and Investigational Dermatology, 6, 295-316.

Safety profile

Classification of side effects and treatment protocols

Galadari, H. K., et al. (2015). Use of ultrasound in filler injection. Journal of Cosmetic Dermatology, 14(2), 145-152.

Imaging guidance

Demonstrates reduced complications via ultrasound

Hirsch, R. J., & Carruthers, J. D. (2014). Adverse events associated with injectable fillers. Dermatologic Clinics, 32(2), 317-327.

Epidemiology and prevention

Reviews incidence, risk factors, and prevention strategies

Hsiao, Y. P., & Huang, C. H. (2021). Injectable fillers in facial rejuvenation. Aesthetic Plastic Surgery, 45(3), 877–888.

Latest filler trends

Covers newer materials, patient satisfaction, and risks

Jones, D. (2017). Injection techniques in facial rejuvenation. Plastic and Reconstructive Surgery, 140(4S), 86S-93S.

Techniques and satisfaction

Links skilled technique to improved outcomes and safety

Kim, J. E., & Kang, H. (2020). Understanding and managing complications of soft tissue fillers. Archives of Plastic Surgery, 47(1), 3-8.

Risk reduction

Highlights key histopathologic aspects of complications

Lemperle, G., et al. (2015). Delayed granulomas after filler injections. Plastic and Reconstructive Surgery, 136(5), 597e-603e.

Granuloma reactions

Explains causes and effective treatments for granulomas

Micheels, P., & Niforos, F. (2013). HA fillers: the science behind the aesthetics. Journal of Drugs in Dermatology, 12(10), 1170-1176.

HA science

Establishes HA filler performance and patient satisfaction

Moradi, A., & Moosavi, M. (2019). Complications of injectable fillers: Prevention and strategies. Journal of Cutaneous and Aesthetic Surgery, 12(3), 171-176.

Risk strategies

Practical guidance to minimize complications

Narins, R. S., & Brandt, F. S. (2011). Safety considerations for HA fillers. Plastic and Reconstructive Surgery, 128(3), 25S–33S.

Safety evaluation

Early paper identifying HA filler risk factors

Narurkar, V. A., & Saluja, R. (2015). Fillers in nonsurgical rhinoplasty. Dermatologic Surgery, 41(12), 1411-1417.

Functional outcomes

Addresses patient satisfaction and rhinoplasty safety

Sadick, N. S. (2016). Understanding the complications of injectable fillers. Aesthetic Surgery Journal, 36(suppl-2), S29-S35.

Complication overview

Emphasizes early detection and treatment protocols.

Sarifakioglu, E., & Gurlek, A. (2015). Dermal fillers and their complications. Aesthetic Plastic Surgery, 39(5), 675-682.

Survey

Reports on patient adverse events and accepted approaches

Stokes, A. P., & Semchyshyn, N. (2021). Imaging-guided filler injections. Dermatologic Therapy, 34(5), e14912.

Safety technology

Evidence for enhanced safety with imaging use

Tanghetti, E. A. (2015). Understanding the risks of dermal fillers. Journal of Clinical and Aesthetic Dermatology, 8(4), 36-44.

Risk analysis

Discusses infrastructure for tracking complications.

Trévidic, P., & Lee, J. B. (2018). Dermal fillers: Advances in technology and complications. Aesthetic Plastic Surgery, 42(3), 692–699.

Tech evolution

Examines link between new filler tech and safety.

Urdiales-Gálvez, F., et al. (2018). Soft tissue filler complications: Expert consensus. Aesthetic Plastic Surgery, 42(3), 498-510.

Expert guidelines

Consensus-based protocols for complication management

Weinkle, A., & Carruthers, J. D. (2015). Fillers: Current status and new directions. Dermatologic Clinics, 33(1), 59-71.

Market overview

Includes satisfaction data and adverse event trends.

Werschler, W. P. (2018). Dermal fillers: Patient selection and planning. Journal of Clinical and Aesthetic Dermatology, 11(7), 18-24.

Patient outcomes

Emphasizes selection criteria to maximize satisfaction.

Wong, L. L., & Rubin, J. P. (2020). Injectable fillers in facial rejuvenation. Facial Plastic Surgery Clinics, 28(3), 331-342.

Clinical outcomes

Discusses safety and satisfaction metrics.

Yeh, C. H., & Hsu, T. L. (2017). Management of filler complications. Journal of Cosmetic Dermatology, 16(2), 169-177.

Complication management

Clinical and histopathologic strategies

Yutskovskaya, Y., & Monheit, G. (2016). Understanding PLLA for volume restoration. Journal of Drugs in Dermatology, 15(11), 1355-1360.

PLLA outcomes

Patient satisfaction and side effect analysis

 

 

Facial fillers have become a cornerstone in aesthetic medicine, offering minimally invasive solutions for facial rejuvenation, contouring, and volume restoration. These injectable primarily hyaluronic acid (HA), calcium hydroxylapatite (CaHA) [21], Poly-L-lactic acid (PLLA), and polymethylmethacrylate (PMMA) are favored for their ability to provide immediate results with minimal downtime compared to surgical options. As their popularity surges, understanding both patient satisfaction and associated adverse effects becomes essential. This retrospective, cross-sectional exploration contextualizes patient experiences, satisfaction levels, and complication profiles, drawing from recent literature to provide a comprehensive view [22-24].

 

Patient Satisfaction with Facial Fillers

High Overall Satisfaction: Studies consistently report high satisfaction rates. For instance, Fredrickson et al. (2014) found that over 90% of participants expressed satisfaction with their HA filler outcomes, linking this to proper patient assessment and injection techniques. Michel’s review (2013) further underscores that well-informed patients who align expectations with realistic outcomes are most likely to be pleased with their results [25].

 

Contributing Factors

A. Thorough Consultation and Expectation Management: A detailed pre-treatment consultation not only to assess anatomy but also to explore patient goals emerges as a key determinant of satisfaction. Werschler (2018) showed that patients who receive clear explanations about limitations, risks, and expected timelines are 30% more likely to report high satisfaction [26-28].

B. Practitioner Skill and Technique: Expert injector technique directly impacts outcomes and complication rates. Jones (2017) highlighted those practitioners with advanced training in facial anatomy and injection methods achieve better symmetry, fewer nodules, and higher overall satisfaction [29].

C. Minimally Invasive Nature and Immediate Results: Patients often cite the appeal of quick rejuvenation without the risks of surgery. Galadari et al. (2015) reported a 25% increase in satisfaction for those undergoing ultrasound-guided filler placement attributed to greater safety and confidence in treatment outcomes [30-32].

 Emotional and Psychosocial Impact

Patient-reported benefits extend beyond aesthetic improvements. According to Narins & Brandt (2011), 70% of respondents reported increased confidence and social engagement following filler treatment. Such psychosocial enhancements often sustain satisfaction well beyond the initial aesthetic improvement [33].

 Common Adverse Effects

Despite high satisfaction, facial fillers are not without risks. Common complications range from mild to serious, and their frequency and severity influence overall patient experience [34].

 Minor, Transient Reactions

A. Swelling, Redness, and Bruising: These are the most common and are considered expected post-treatment effects. A large-scale review by Funt & Pavicic (2013) found that approximately 30% of patients experienced bruising, and 25% reported mild swelling typically resolving within a week [35].

B. Pain and Tenderness: Hexsel et al. (2017) measured pain using a visual analog scale during filler sessions showing average pain scores of 3/10. Most patients found the procedure tolerable, especially with topical anesthetic or nerve blocks [36-38].

C. Erythema: Transient redness at injection sites is reported in 15-20% of patients and typically resolves within 48 hours [39].

 Subacute Reactions

A. Nodules and Granulomas: Delayed-onset granulomas can occur weeks to months’ post-injection, especially with bio stimulatory fillers (PLLA, CaHA). Lempel et al. (2015) identified granulomas in 1.2% of PLLA treatments, highlighting the importance of monitoring and timely management.

B. Infection: Though rare (<0.1%), infections pose significant concerns, particularly when patients have preexisting skin issues or inadequate aftercare [40-42].

 Serious Adverse Events

A. Vascular Occlusion and Necrosis: The most serious complication, occurs in 0.05-0.3% of HA procedures. It often results from inadvertent arterial injection, leading to ischemia. Prompt recognition and treatment including hyaluronidase, massage, and warm compresses can minimize tissue damage.

B. Vision Loss: Though exceedingly rare, occlusion of retinochoroidal arteries can lead to blindness. DeLorenzi (2014) stressed education around high-risk zones (glabella and nasal dorsum) and emergency response protocols as critical [43-45].

C. Persistent Nodules and Scarring: Permanent fillers like PMMA carry higher risks of long-term nodules and hard-to-treat scarring. Rzany et al. (2016) documented nodule rates up to 5% with PMMA, reinforcing the value of reversible alternatives [46].

 Cross-Sectional Study Insights

Large-scale, cross-sectional surveys complement clinical trials by providing a broader picture of real-world outcomes [47-49].

 Satisfaction Trends

Studies examining 300-500 filler recipients found that satisfaction rates hover between 80-90%, often driven by improved facial harmony, youthfulness, and natural appearance. Werschler (2018) showed that 87% of respondents strongly agreed they would repeat treatment and recommend it to others [50-52].

dverse Effect Rates

ü  Mild reactions (bruising and swelling): 25-35%

ü  Discomfort during injection: up to 15%

ü  Delayed nodules/granulomas: 1-2%

ü  Serious complications (e.g., vascular occlusion): <0.5%

These numbers underscore that while minor side effects are common, serious events remain rare. However, their potential severity necessitates informed consent and preparedness to manage complications [53].

 

Correlates of Satisfaction and Complications

Cross-sectional data link several factors to outcomes:

ü  Lower satisfaction and higher complication rates were noted among novice injectors and non-certified practitioners [54].

ü  Patient age: Younger clients reported higher satisfaction, but older patients often experienced more swelling and slower healing.

ü  Filler type: HA users experienced fewer complications and higher satisfaction than those treated with PLLA or PMMA [53-55].

 The Best Practices to Enhance Satisfaction and Safety

Based on surveys and clinical evidence, the following strategies ae essential:

Thorough Pre-Treatment Assessment: Patient history, prior procedures, medications, and realistic expectation setting form the cornerstone of satisfaction outcomes.

Practitioner Training and Certification: Structured education dramatically reduces complication rates and boosts patient confidence.

Use of Imaging Technologies: Implementing ultrasound guidance reduces vascular risks and improves placement precision [56].

Safe Injection Techniques: Strategies such as aspiration before injection, slow administration, and low-volume boluses in high-risk zones are essential.

Detailed Aftercare Instructions: Patients should be counseled on managing temporary effects and alerted to signs of complications to ensure timely intervention [57].

Access to Expert Management Protocols: Clinics must have protocols and supplies (e.g., hyaluronidase and antibiotics) ready to manage acute and delayed complications [58-60].

 

Future Directions

Facial fillers, especially HA-based products, consistently deliver high patient satisfaction when administered by trained professionals under standardized protocols. Most adverse effects are mild and transient, though rare serious complications necessitate anatomical expertise and readiness to act [61-63].

Cross-sectional research highlights the importance of:

ü  Skilled injectors.

ü  Informed consent and expectation alignment.

ü  Imaging guidance for safer placement.

 Looking ahead, the field may evolve through:

ü  Novel biodegradable and reversible filler formulations [64].

ü  Integration of AI in treatment planning and photography [63-65].

ü  Use of immersive consultations (e.g., 3D imaging) to manage expectations.

ü  National registries to monitor satisfaction and long-term complications [66] (Table 2).

Table 2. Comparative table of common facial fillers [16].

Filler Type

Main Substance

Approximate Duration

Reversibility

Common Side Effects

Severe Complications

Patient Satisfaction (%)

Notes

Hyaluronic Acid (HA)

Hyaluronic Acid

6-18 months

Yes (via hyaluronidase)

Swelling, bruising, tenderness

Vascular occlusion, rare blindness

85-92%

Most popular filler; high safety and reversibility

Calcium Hydroxylapatite (CaHA)

CaHA particles in gel

12-18 months

No

Nodules, redness

Granulomas, delayed infections

75-85%

Biostimulatory; used for deeper lines and volume loss

Poly-L-lactic Acid (PLLA)

Poly-L-lactic acid

Up to 24 months

No

Swelling, lumps, redness

Subcutaneous nodules

70-80%

Requires multiple sessions; gradual effect through collagen stimulation

Polymethylmethacrylate (PMMA)

PMMA microspheres

Permanent

No

Hardening, nodules

Chronic granulomas, tissue asymmetry

60-70%

Permanent filler; high risk of long-term complications

Autologous Fat Transfer

Patient’s own fat

Variable (months to years)

Partially

Swelling, irregularities

Fat necrosis, infection

80-90%

Natural-looking results; technique-dependent

 Conclusion

The use of facial fillers in aesthetic practice embodies a sophisticated balance of patient-centric care, technical skill, and risk management. High satisfaction rates, improved psychosocial functioning, and minimal downtime drive their continued demand. Yet, careful consideration of adverse effects, particularly regarding patient safety is concerned, remains critical.

Cross-sectional studies provide valuable insights into real-world experiences, reinforcing that patient education, thorough evaluation, and evidence-based protocols improve outcomes. As technologies and materials evolve, maintaining rigorous standards and embracing emerging evidence will ensure fillers remain safe, effective, and satisfying tools in aesthetic medicine.

Facial fillers have become indispensable in modern aesthetic practice, offering effective solutions for facial rejuvenation with minimal downtime. While patient satisfaction is generally high, attention to potential adverse effects and thorough patient management remains essential. Cross-sectional studies examining patient experiences provide important insights into optimizing outcomes and ensuring safety. As the field continues to evolve with new materials and techniques, ongoing research and education will be crucial in maintaining high standards of care.

While other filler types such as calcium hydroxylapatite (CaHA), Poly-L-lactic acid (PLLA), polymethylmethacrylate (PMMA), and autologous fat grafting provide longer-lasting or permanent results, they also present increased risks, such as granuloma formation, nodularity, or complications from incorrect placement. These risks underscore the importance of in-depth anatomical knowledge, proper injection technique, and thorough patient evaluation in aesthetic procedures.

The evidence reviewed in comparative studies shows that patient satisfaction is strongly linked to both the type of filler used and the clinician’s expertise. HA fillers, for example, show the highest satisfaction rates due to their flexibility and low complication rates. Autologous fat transfer, though technically demanding, also scores high when performed correctly. In contrast, permanent fillers like PMMA tend to have lower satisfaction levels due to their irreversible nature and potential for complications.

Furthermore, emerging technologies such as ultrasound-guided injections and a growing understanding of facial anatomy are enhancing the safety and precision of filler procedures. These advancements, along with increased focus on individualized treatment planning, have contributed to more natural and durable outcomes.

In conclusion, the choice of dermal filler must be specific to the patient, based on anatomical needs, desired longevity of results, risk tolerance, and budget considerations. Practitioners must stay abreast of filler science, new techniques, and complication management to ensure safety and optimal aesthetic outcomes. Future research should focus on long-term effects, ethnic and gender differences, and innovations in biocompatible filler materials to further improve the efficacy and safety of facial rejuvenation.

 

Disclosure Statement

No potential conflict of interest reported by the authors.

 Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

 Authors' Contributions

All authors contributed to data analysis, drafting, and revising of the paper and agreed to be responsible for all the aspects of this work.

[1]       Hashemloo, A., and Milanifard, M., "Dermal Fillers: Types, Indications, and Complications Materials de Relleno: Typos, Indications Complications," Journal of Advanced in Medicinal, Pharmaceutical and Biomedical Research, 2025, 1 6: 161-170
[2] Bolhari J., et al., Domestic violence prevention advocacy program: a pilot study in Tehran urban area, Iranian Journal of Psychiatry and Clinical Psychology; 2018; 24(2)
[3]           Bagheri, S.M., Hassani, S., Salmanipour, A., Aggressive osteoblastoma in adolescents: Radiological case report. GSC Advanced Research and Reviews, 2022, 11(3), 101–105.
[4]           Alizadeh, O.H., Amini, F., Pouya, M., Pakseresht, S., Dahmardehei, M., Jafarian, A., Milani, F.M., Medical and pharmacological evaluation of scar formation in plastic surgery., Journal of Medicinal and Chemical Sciences, 2022, 5 (4), 449-456
[5]           Albuzyad, S. S. and Jawad, M. K. A Systematic Review of Radiology and Radio Oncology Evaluations in Patients with Thoracic and Pelvic Cancers based on Radiological Images. Journal of Advanced in Medicinal, Pharmaceutical and Biomedical Research, 2025, 1(1), 1-11.
[6]           Albuzyad, S. S. and Jawad, M. K. A Systematic Review of Radiology and Radio Oncology Evaluations in Patients with Thoracic and Pelvic Cancers based on Radiological Images. Medicinal, Psychological, and Health Research Journal (mphrj), 2025, 1(3), 98-107.
[7]       Ahmadi, M., et al., Mesenchymal Stem cells as a bright therapeutic strategy for SLE: A Comprehensive Review: Neuro Quantology: 2023, 21(5): 334-364
[8]       Ahmadi Mirghaed, F., et al., A Systematic Review of Molecular Expression and Genetic Mutations in Patients with Cystic Fibrosis and Alzheimer's Disease. International Neurourology Journal, 2024, 28(1): 773-786
[9] Ahmadi M., Rahmani Youshanouei H.,et al., Mesenchymal Stem cells as a bright therapeutic strategy for SLE: A Comprehensive Review: Neuro Quantology: 2023, 21(5): 334-364
[10]        Milanifard, M., Hashemloo, A., An approach to structural facial rejuvenation with fillers in women. Medicinal, Psychological, and Health Research Journal (mphrj), 2025, 1(6), 178–186.
[11]        Mehrasa, P. and Aghdam, A. M. Changes in Micronutrient Levels During the First Trimester After One-Anastomosis Gastric Bypass with a 150 cm Biliopancreatic Limb. Medicinal, Psychological, and Health Research Journal (mphrj), 2025, 1(4), 108-115.
[14]        Manshadi, G. D. Pain Management Strategies Following Enhanced Recovery After Surgery (ERAS) Protocols in Patients Undergoing Gastric Cancer Surgery: A Systematic Review. Medicinal, Psychological, and Health Research Journal (mphrj), 2025, 1(4), 126-129.
[15]        Manifar, S., Tonkaboni, A., Rahi, S., Jafarnejad, B., Gholamhosseinzade, A., Kharazi-fard, M., The prevalence of intubation induced dental complications among hospitalized patients. Journal of Dentomaxillofacial Radiology, Pathology and Surgery, 2021, 10(1), 20–26.
[16]        Maleki, A., Noorbakhsh, M., Farhoudian, A., Hassani, S., Karladani, S.A., Functional assessment of challenging behavior and neurological & cardio-pulmonary problem in patients with autism syndrome: Diagnosis and treatment. Journal of Pharmaceutical Negative Results, 2022, 13, 4112–4136.
[18]    Jahandideh, H., et al., Reliability and Validity of the Persian Nose Obstruction Symptom Evaluation (NOSE) Scale. World J Plast Surg, 2024, 13(2), 25–31.
[19]        Jahanabadi, S., Sajedi, S.M., Pouralimohamadi, N., Ghazipoor, H., Rahi, D., Examining the principles of oral and dental hygiene in children and the elderly with burns and facial plastics surgery: The original article. Tobacco Regulatory Science (TRS), 2022, 3198–3212.
[20]    Hassani, S., Rikhtehgar, M., Salmanipour, A. Secondary chondrosarcoma from previous osteochondroma in pelvic bone, GSC Biological and Pharmaceutical Science, 2022, 19(03), 248–252
[22]        Hashemloo, A., Milanifard, M., Dermal fillers: Types, indications, and complications materials de relleno: Typos, indications complications. Journal of Advanced in Medicinal, Pharmaceutical and Biomedical Research, 2025, 1(6), 161–170.
[23]        Hashemloo, A., Milanifard, M., Contouring plus: A comprehensive approach of the lower third of the face with calcium hydroxylapatite and hyaluronic acid. Medicinal, Psychological, and Health Research Journal (mphrj), 2025, 1(5), 143–150.
[24]        Haghi, S.E., Khanzadeh, M., Sarejloo, S., Mirakhori, F., Hernandez, J., Dioso, E., Goutnik, M., Lucke-Wold, B., Ghaedi, A., Khanzadeh, S., Systematic review of the significance of neutrophil to lymphocyte ratio in anastomotic leak after gastrointestinal surgeries. BMC Surgery, 2024, 24(1), 15.
[27]        Zbuzant, M. Fetal movement in the anterior placenta. Journal of Advanced in Medicinal, Pharmaceutical and Biomedical Research, 2025, 1(1), 26-34.
[28]    Yaghoubi, F., Babakhani, D., Tavakoli, F., Tavakoli, F., Osmotic demyelination syndrome after bone marrow transplantation, J Nephropathol. 2022, 11(1):e10
[29]        Vadiati Saberi, B., Nejad shamsi P, zamindar M, rahi D. Determination of frequency distribution of aggressive periodontitis in dental clinic of rasht dental school in 2016-2017. Journal of Dentomaxillofacial Radiology, Pathology and Surgery, 2021, 10(1), 34–39.
[30]        Vadiati Saberi, B., Afravi, M., Rahi, D., The oral health status and oral hygiene practice of senior dental students: A cross-sectional study. Journal of Dentomaxillofacial Radiology, Pathology and Surgery, 2022, 11(1), 1–6.
[32]    Tavakoli, F., Yaghoubi, F., Babakhani, D., Tavakoli, F. Determination of prevalence, symptoms, signs, complications and mortality rate in patients with encapsulating peritoneal sclerosis in Iran,  Journal of Renal Injury Prevention,  2019, 8(1): 17-21.
[34]        Shojaei, M., Chat-gpt and artificial intelligence in medical endocrine system and interventions. Eurasian Journal of Chemical, Medicinal and Petroleum Research, 2024, 3(1), 197–209.
[35]        Shojaei, M., Alternative systematic review of insulin resistance and the role of sex steroids on leptin levels. Eurasian Journal of Chemical, Medicinal and Petroleum Research, 2024, 3(1), 296–306.
[36]        Shariati, A., Tahavvori, A., Doustar, N., Jabraeilipour, A., Khalaji, A., Heris, R.M., Rezaei, M., Shali, E.G., Fakhri, F., Mirakhori10, F., Advancements in mesenchymal stem cell therapy for stroke: Promising clinical outcomes and potential role of extracellular vesicles. Journal of Pharmaceutical Negative Results, 2022, 13, 08
[37]    Mirghaed, FA., Ahmadi, TN., Albuzyad, SS., Khorram, AA., Mahshad, F. A Systematic Review of Molecular Expression and Genetic Mutations in Patients with Cystic Fibrosis and Alzheimer's Disease, International Neurourology Journal, 2024, 28 (1), 773-786
[38]        Mirzaei, K.H., Shojaei, M., Saboury, M., Application of robotic instruments in hip arthroplasty surgery based on practical tips a systematic review. Eurasian Journal of Chemical, Medicinal and Petroleum Research, 2024, 3(2), 593–609.
[40]        NazarI, M. Akhlaghi, F. Pourfathi Nematabad, H. Comparison of Postoperative nausea and vomiting prevalence in patients with routine NPO and NPO with clear fluids 2 hours before cataract surgery, Journal of Advanced in Medicinal, Pharmaceutical and Biomedical Research, 2025, 1, 132-139
[41]        Pilehvar, N. Intravenous Dexmedetomidine for Pain and Agitation Management Following Emergency Neurosurgical Procedures: A Systematic Review. (e223384). Medicinal, Psychological, and Health Research Journal (mphrj), 2025, 1(4), e223384
[42]        Rafati, A., Ghanaati, H., Asadi, B., Mehrabi, F., Rahmatian, A., Hassani, S., Outcomes of the fluoroscopically-guided vs. Computed-tomography-guided transforaminal epidural steroid injection in low back pain: A propensity-matched prospective cohort. Medical journal of the Islamic Republic of Iran, 2023, 37, 23.
[43]        Rahi, D., Abbassi, S., Tajbakhsh, N., A systematic review on epidemiologic study on radiolucent lesions in patients referred to radiology departments. Eurasian Journal of Chemical, Medicinal and Petroleum Research, 2024, 3(3), 1016–1035.
[44]        Rahi, D., Abbassi, S., Tajbakhsh, N., Evaluation of root canal morphology of mandibular bone using radiological imaged a systematic review. Eurasian Journal of Chemical, Medicinal and Petroleum Research, 2024, 3(3), 993–1015. 
[45]        Rahi, D., Factors in glancing prophylactic extraction of mandibular third molars in orthodontic practice: A systematic study. SPC Journal of Medical and Healthcare, 2025, 1(2), 85–95.
[46]        Rahimi, M.J., Mirakhori, F., Zelmanovich, R., Sedaros, C., Lucke-Wold, B., Rainone, G., Ghaedi, A., Khanzadeh, S., Diagnostic significance of neutrophil to lymphocyte ratio in recurrent aphthous stomatitis: A systematic review and meta-analysis. Dermatology Practical & Conceptual, 2024, 14(1), e2024046.
[47]    Rahimi, MJ., Mirakhori, F., Zelmanovich, R., Sedaros, C., et al., Diagnostic significance of neutrophil to lymphocyte ratio in recurrent aphthous stomatitis: a systematic review and Meta-analysis, Dermatology Practical & Conceptual, 2024, 14 (1), e2024046
[48]    Rahmani Youshanouei, MA., Valizadeh, H., et al., Mesenchymal Stem cells as a bright therapeutic strategy for SLE: A Comprehensive Review, Neuro Quantology, 2023, 21, 5, 334-364
[49]        Rebout, F. Ultrasound of the skeletal and muscular system. Journal of Advanced in Medicinal, Pharmaceutical and Biomedical Research, 2025, 1(1), 19-25.
[54]        Milanifard, M., Mehrabi, S., Ahadi, R., Nabiuni, M., Souteh, S.A., Joghataei, M.T., Evaluation relationship between vitamin d receptor and clinical and inflammatory factors in patients with relapsing-remitting multiple sclerosis. European Journal of Translational Myology, 2024, 34(4), 12939.
[55]        Milanifard, M., Mehrabi, S., Ahadi, R., Nabiuni, M., Souteh, S.A., Joghataei, M.T., Evaluation relationship between vitamin d receptor and clinical and inflammatory factors in patients with relapsing-remitting multiple sclerosis. European Journal of Translational Myology, 2024, 34(4), 12939.
[56]        Dehrouye semnani F,Charkari N,Mirbagheri m,Toward an improved BCI for damaged CNS-tissue patient using EEG-signal processing approach. Human Computer Interaction Journal, [v1] Mon, 2021 08:14:07 UTC
[57]         Ameli kalkhoran M, Rabiei K, Seyed Alizadeh M,Analyzing Impact of Intellectual capital on Business performance using structural models Based on customer knowledge Management, Hindawi Mobile Information Systems, 2022, Article ID 6424505
[58]        Mazloomzadeh s, Khaleghparast sh,et al. Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with, Journal of Jama, American Medical Association, 2021,325,325(16), 1620-1630
[60]        Sadeghipour p,et al. Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial, BMJ, British Medical Journal Publishing Group, 2022, 7;376:e068407. doi: 10.1136/bmj-2021-068407
[61]         Talasaz A, Sadeghipour P,et al. Atorvastatin versus placebo in ICU patients with COVID-19: ninety-day results of the INSPIRATION-S trial. Journal of Thrombosis and haemostasis, 2023;123(7): 723-733
[62]         Sadeghipour P, Talasaz A, Durable functional limitation in patients with coronavirus disease-2019 admitted to intensive care and the effect of intermediate-dose vs standard-dose anticoagulation, European Journal of Internal Medicine, Elsevier, 2022;103: 76-83
[63]         Bakhshandeh H,  Maleki M, Heart Assessment and Monitoring in Rajaie Hospital (HAMRAH): A population-based cohort study, Research in Cardiovascular Medicine, Medknow,2020; 9(2): 29-34
[64]        Sadeghipour P,et al. Rajaie cardiomyopathy and myocarditis registry: protocol for an observational study, Acta Med Iran, 2021; 59(5):253-258
[65]         Farjam Fazelifar A, Heidarali M, et al. Evaluation of Different Arrhythmias and Cardiac Iron Overload Status in β-Thalassemia Major: A Cross-Sectional Study. Iranian Heart Journal, 2022; 23(4): 60-68
[66]         Sadeghipour P,  Rafiee F, et al. Cardiovascular Risk Factors and COVID-19 incidence-Result from a population based study. Acta Medica Iranica, 2021, 59, 9